Evans syndrome during pembrolizumab therapy for upper urinary tract cancer

INTRODUCTION: Immune checkpoint inhibitors are available for the treatment of advanced urothelial carcinoma; however, serious adverse events occasionally occur. Here, we report a rare case of Evans syndrome attributed to the use of an immune checkpoint inhibitor. CASE PRESENTATION: A 56‐year‐old man...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakita, Shota, Matsuo, Tomohiro, Ohki, Masaharu, Tsuchiyama, Ayaka, Yasuda, Takuji, Nakanishi, Hiromi, Mitsunari, Kensuke, Ohba, Kojiro, Imamura, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475338/
https://www.ncbi.nlm.nih.gov/pubmed/37667757
http://dx.doi.org/10.1002/iju5.12609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475338/
https://www.ncbi.nlm.nih.gov/pubmed/37667757
http://dx.doi.org/10.1002/iju5.12609

Ejemplares similares